Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics such as antibody drug conjugates, bispecific antibodies and overcoming the blood-brain barrier.
Sessions for the Conference:
- Novel Antibody Targets
- Antibody Selection Methods & Strategies
- Bispecific Antibodies & Fusion Proteins
- Immunomodulatory Biotherapy for Cancer
- Next Generation of Protein Engineering
- Combining Antibody Therapeutics